Tatiana Novobrantseva

Tatiana Novobrantseva

Company: Verseau Therapeutics

Job title: Co-Founder & CSO


Finding Novel Targets to Harness Myeloid Repolarization, Demonstrating Functional Change & Anti-Tumor Activity in Preclinical Development 5:00 pm

• Defining the term ‘repolarization’ in the context of myeloid cells: recruiting new macrophages vs. changes in tumor-resident macrophages • Maintaining myeloid cells ex vivo and characterizing the function of M1 vs. M2 phenotypes to determine anti-tumor effects • Leveraging functional information to identify and validate myeloid targets for clinical developmentRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.